Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that Peony-Glycyrrhiza Decoction (PGD) adjunctive therapy could
reduce the incidence of prolactin (PRL)-related adverse events in patients with schizophrenia
and suppress antipsychotic-induced elevation of PRL levels.
This is a placebo-controlled trial conducted in schizophrenic patients to determine whether
PGD adjunctive treatment could produce greater biochemical and clinical improvement on
hyperprolactinemia (hyperPRL) compared to placebo treatment.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Hong Kong
Collaborators:
Capital Medical University Kowloon Hospital, Hong Kong Queen Mary Hospital, Hong Kong Xijing Hospital